Phase 1 Test-retest Evaluation of [18F]MK-6240 PET as an Imaging Marker for Neurofibrillary Tangles in the Brain of Patients With Alzheimer's Disease Compared to Healthy Volunteers

Trial Profile

Phase 1 Test-retest Evaluation of [18F]MK-6240 PET as an Imaging Marker for Neurofibrillary Tangles in the Brain of Patients With Alzheimer's Disease Compared to Healthy Volunteers

Recruiting
Phase of Trial: Phase I

Latest Information Update: 09 Mar 2017

At a glance

  • Drugs Fluorine-18-MK 6240 (Primary) ; Florbetapir F 18
  • Indications Alzheimer's disease
  • Focus Diagnostic use
  • Sponsors Molecular NeuroImaging
  • Most Recent Events

    • 09 Mar 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top